HROW vs JBIO
Comparison between Harrow Inc (HROW, Company) and Jade Biosciences Inc (JBIO, Company).
Both HROW and JBIO are from the Healthcare sector.
5-Year PerformanceHROW has outperformed JBIO, delivering a return of +33.9% compared to -41.7%
HROW vs JBIO - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
HROW vs JBIO - Historical Returns
Returns include dividend reinvestment.
HROW vs JBIO - Annual Returns (2007 - 2026)
Returns include dividend reinvestment.
| Year | HROW | JBIO |
|---|---|---|
| 2026 | -22.12% | +68.15% |
| 2025 | +34.03% | -79.69% |
| 2024 | +180.75% | -87.85% |
| 2023 | -24.22% | -16.28% |
| 2022 | +70.44% | +168.07% |
| 2021 | +17.55% | -48.36% |
| 2020 | -6.03% | N/A |
| 2019 | +51.07% | N/A |
| 2018 | +228.90% | N/A |
| 2017 | -31.17% | N/A |
| 2016 | -63.24% | N/A |
| 2015 | -8.09% | N/A |
| 2014 | +107.76% | N/A |
| 2013 | -61.60% | N/A |
| 2012 | +204.69% | N/A |
| 2011 | -84.81% | N/A |
| 2010 | -45.52% | N/A |
| 2009 | +50.00% | N/A |
| 2008 | -63.64% | N/A |
| 2007 | -8.33% | N/A |
HROW vs JBIO Drawdown Comparison
The maximum drawdown for HROW was -99.46%, occurring on Mar 19, 2012. This drawdown has not yet recovered.
The maximum drawdown for JBIO was -99.22%, occurring on Jun 13, 2025. This drawdown has not yet recovered.
The current HROW drawdown is -71.83%. The current JBIO drawdown is -97.26%.
| Rank | HROW | JBIO |
|---|---|---|
| #1 | -99.46% Oct 4, 2007 - Mar 19, 2012 | -99.22% Apr 1, 2024 - Jun 13, 2025 |
| #2 | N/A | -68.61% Dec 12, 2022 - Apr 1, 2024 |
| #3 | N/A | -63.86% Jun 30, 2021 - Aug 1, 2022 |
| #4 | N/A | -42.73% Aug 12, 2022 - Dec 12, 2022 |
| #5 | N/A | -4.56% Aug 5, 2022 - Aug 12, 2022 |
Correlation
Correlation between HROW and JBIO is -0.79 which considered as a strong negative correlation - the stocks tend to move in opposite directions.
Select Stocks to Compare
More Comparisons
Compare with similar stocks